Pds Biotechnology earnings were -$32.3M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest PDSB earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$7.6M, down 21.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PDSB reported annual earnings of -$34.5M, with -8.3% growth.
What were Pds Biotechnology's earnings last quarter?
On PDSB's earnings call on Nov 13, 2026, Pds Biotechnology (NASDAQ: PDSB) reported Q3 2026 earnings per share (EPS) of -$0.11, up 42.11% year over year. Total PDSB earnings for the quarter were -$7.62 million. In the same quarter last year, Pds Biotechnology's earnings per share (EPS) was -$0.19.
As of the last Pds Biotechnology earnings report, Pds Biotechnology is currently losing money. Pds Biotechnology's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$32.28 million, a 7.46% decrease year over year.
What was PDSB's earnings growth in the past year?
As of Pds Biotechnology's earnings date in Nov 13, 2026, Pds Biotechnology's earnings has grown year over year. PDSB earnings in the past year totalled -$32.28 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.